AJP - Heart Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 260: H957-H966, 1991;
0363-6135/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minkes, R. K.
Right arrow Articles by Kadowitz, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minkes, R. K.
Right arrow Articles by Kadowitz, P. J.

AJP - Heart and Circulatory Physiology, Vol 260, Issue 3 957-H966, Copyright © 1991 by American Physiological Society

ARTICLES

Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels

R. K. Minkes, P. Kvamme, T. R. Higuera, B. D. Nossaman and P. J. Kadowitz
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112.

Cardiovascular and pulmonary responses to cromakalim, a member of a novel class of antihypertensive agents that open ATP-sensitive K+ (K+ATP) channels, were investigated in the anesthetized cat. Intravenous injections of cromakalim in doses of 30-300 micrograms/kg decreased arterial pressure (AP), pulmonary arterial pressure (PAP), and increased cardiac output (CO), while producing small changes in right and left atrial pressures. Pulmonary and systemic vascular resistances were decreased and vasodilator responses to cromakalim were blocked by glybenclamide, a K+ATP channel-blocking agent. The low dose of cromakalim caused a reflex increase in heart rate (HR) and right ventricular contractile force (RVCF), whereas the high dose decreased HR and RVCF. Under constant-flow conditions the K+ATP channel opener caused dose-dependent decreases in hindquarters perfusion pressure, and when tone was elevated in the pulmonary vascular bed, dose-dependent decreases in pulmonary lobar arterial perfusion pressure. Hindquarters and pulmonary lobar vasodilator responses to cromakalim were inhibited in a specific manner by glybenclamide. The present data show that cromakalim has significant vasodilator activity in both the systemic and pulmonary vascular beds and suggest that responses to this agent result from activation of glybenclamide-sensitive K+ATP channels. These data show that cromakalim can cause substantial decreases in systemic and pulmonary vascular resistance in a dose that has little effect on RVCF.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Duncker, H. H. Oei, F. Hu, R. Stubenitsky, and P. D. Verdouw
Role of KATP+ channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H22 - H33.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. R. Kersten, M. W. Montgomery, P. S. Pagel, and D. C. Warltier
Levosimendan, a New Positive Inotropic Drug, Decreases Myocardial Infarct Size via Activation of KATP Channels
Anesth. Analg., January 1, 2000; 90(1): 5 - 5.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. Keyes, D. M. Rodman, D. Curran-Everett, K. Morris, and L. G. Moore
Effect of K+ATP channel inhibition on total and regional vascular resistance in guinea pig pregnancy
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H680 - H688.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online